Welcome to the e-CCO Library!

DOP054: Discrepancies between patient-reported outcomes, endoscopic, and histologic appearance in ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J.-F. Colombel*1, M. Keir2, A. Scherl2, R. Zhao2, G. de Hertogh3, W. Faubion4, T. Lu2

Created: Friday, 22 February 2019, 9:49 AM
DOP054: High-throughput sequencing of T cell receptors from pediatric ulcerative colitis patients reveals distinct tissue-specific repertoires
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Werner L.1, Nunberg M.1, Haberman Y.1, Lahad A.1, Turner D.2, Weiss B.1, Shouval D.*1

Created: Wednesday, 20 February 2019, 10:36 AM
DOP054: Vedolizumab in combination with steroids for induction therapy in Crohn’s disease: an exploratory analysis of the GEMINI 2 and GEMINI 3 studies
Year: 2018
Source: ECCO '18 Vienna
Authors:

B.E. Sands1, G. Van Assche2, D. Tudor3, T. Tan4*

Created: Thursday, 21 February 2019, 9:14 AM
DOP055: Azithromycin based therapy for induction of remission in mild to moderate active paediatric Crohns disease: the Multicentre azithromycin for Crohns disease AZCRO trial
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Levine*1, 2, J. Kierkuś3, M. Kori4, M. Sladek5, R. Sigall Boneh1, J. Escher6, E. Wine7, B. Yerushalmi8, J. Amil Dias9, R. Shaul10, A. Akriv11, D. Zucker11, D. Turner11, 12

Created: Friday, 22 February 2019, 9:49 AM
DOP055: Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active ulcerative colitis patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Atreya1*, T. Kühbacher2,3, H. Schmitt1, S. Hirschmann1, M.J. Waldner1, O. Drvarov2, S. Fischer1, M. Vetter1, B. Weigmann1, A. Turowska4, T. Mühl4, U. Homburg4, J. Renz4, M. Vieth5, H. Garn6, H. Renz6, M.F. Neurath1

Created: Thursday, 21 February 2019, 9:14 AM
DOP055: Results of the Fifth Scientific Workshop of the ECCO (II): clinical aspects of perianal fistulising Crohn's disease – the unmet needs
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Gecse K.*1, Sebastian S.2, De Hertogh G.3, Yassin N.4, Kotze P.5, Reinisch W.6, Spinelli A.7, Koutroubakis I.8, Katsanos K.9, Hart A.10, van den Brink G.11, Rogler G.12, Bemelman W.13

Created: Wednesday, 20 February 2019, 10:36 AM
DOP056: Efficacy and safety of anti-fractalkine monoclonal antibody, E6011, in patients with Crohn’s disease who had lost response to anti-TNFα agents: A multicentre, open-label, Phase 1/2 study
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Matsuoka1*, M. Naganuma2, S. Tanida3, K. Kitamura4, T. Matsui5, M. Arai6, M. Fujiya7, N. Horiki8, H. Nebiki9, F. Kinjo10, T. Miyazaki11, T. Matsumoto12, M. Esaki13, K. Mitsuyama14, M. Saruta15, A. Ido16, S. Hojo17, O. Takenaka17, K. Oketani18, T. Imai19, H. Tsubouchi20, T. Hibi21, T. Kanai2

Created: Thursday, 21 February 2019, 9:14 AM
DOP056: Pathophysiology of perianal fistulising disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Siegmund B.1, Feakins R.M.2, Barmias G.3, Coelho Ludvig J.4, Vieira Teixeira F.5, Rogler G.6, Scharl M.*7

Created: Wednesday, 20 February 2019, 10:36 AM
DOP056: Pharmacokinetics and exposure-response relationships of golimumab in paediatric patients with moderate-to-severe ulcerative colitis: results from a multicentre open-label study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

O. J. Adedokun*1, D. Chan1, L. Padgett1, Y. Xu1, J. Hyams2, D. Turner3, Z. Xu1, H. Davis1, R. Strauss1

Created: Friday, 22 February 2019, 9:49 AM
DOP057: ECCO-EBMT joint paper: autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn’s disease: Summary of the ECCO-EBMT joint review
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Snowden1*, J. Panes2, T. Alexander3, M. Allez4, S. Ardizzone5, D. Dierickx6, J. Finke7, P. Hasselblatt7, C. Hawkey8, M. Kazmi9, J. Lindsay10, F. Onida11, A. Salas2, R. Saccardi12, S. Vermeire13, M. Rovira14, E. Ricart2

Created: Thursday, 21 February 2019, 9:14 AM
DOP057: Perianal pediatric Crohn's disease is associated with a distinct phenotype and greater inflammatory burden
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Assa A.*1, Amitai M.2, Greer M.-L.3, Castro D.3, Cytter Kuint R.4, Martínez-Leόn M.5, Herman-Sucharska I.6, Coppenrath E.7, Anupindi S.8, Towbin A.9, Moote D.10, Konen O.11, Pratt L.-T.12, Grifitths A.3, Turner D.4

Created: Wednesday, 20 February 2019, 10:36 AM
DOP057: Tailored step-up approach results in beneficial long-term disease outcome in the prospective Belgian registry of paediatric Crohns disease (BELCRO)
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

L. Wauters*1, F. Smets2, E. De Greef3, I. Hoffman4, P. Bontems5, S. Van Biervliet6, I. Paquot7, P. Alliet8, W. Arts9, M. De Vos10, P. Bossuyt11, J.-F. Rahier12, O. Dewit13, T. Moreels13, D. Franchimont14, V. Muls14, F. Fontaine15, E. Louis15, J.-C. Coche16, B. Hauser3, H. Peeters17, E. Van de Vijver18, F. Baert19, S. Vermeire1, G. Veereman3

Created: Friday, 22 February 2019, 9:49 AM
DOP058: Combined stem cells and anticytokine therapy contributes to a more pronounced decrease in the degree of inflammation of the intestinal mucosa in Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Fadeeva1*, O. Knyazev1, A. Kagramanova1, E. Dobroluybova1, I. Donchenko1, S. Khomeriki2, A. Babayan1, A. Lishchinskaya3, A. Konoplyannikov4

Created: Thursday, 21 February 2019, 9:14 AM
DOP058: Does biologic therapy increase the risk for fistula-associated mucinous adenocarcinoma in long standing perianal Crohn's disease?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Laureti S., Coscia M., Gentilini L., Gionchetti P., Renzi N., Rizzello F., Tanzanu M., Poggioli G.

Created: Wednesday, 20 February 2019, 10:36 AM
DOP058: Long-term avoidance of steroids associated with exclusive enteral nutrition as induction therapy in paediatric Crohns disease does not increase surgery, hospitalisations or biologics use: results of a propensity score-matched cohort analysis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Basseri1, J. Connors2, A. Grant2, B. MacIntyre2, N. Giffin1, G. Mahdi2, A. Noble2, M. Rashid2, A. R. Otley2, J. Van Limbergen*2

Created: Friday, 22 February 2019, 9:49 AM
DOP059: Combined anticytokine and local mesenchymal stem cells therapy promotes longer healing of simple fistulas in patients with Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Belyakov1*, O. Knyazev1, N. Fadeeva1, N. Orlova2, A. Konoplyannikov3, A. Parfenov1

Created: Thursday, 21 February 2019, 9:14 AM
DOP059: Efficacy of exclusive enteral nutrition in adult active Crohns disease with complications or failure of medical treatment
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Q. Yang, X. Gao*, M. Zhi, H. Chen, N. Ding, S. Hu, J. Guo, P. Hu

Created: Friday, 22 February 2019, 9:49 AM
DOP059: New human gut xenograft mouse model for intestinal fistulas
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bruckner R.S.*1,2, Marsiano N.3, Nissim-Eliraz E.3, Nir E.3, Lang S.1,2, Spalinger M.1,2, Rogler G.1,4, Yagel S.5, Scharl M.1,4, Shpigel N.Y.3 SysmedIBD EU Research Consortium

Created: Wednesday, 20 February 2019, 10:36 AM
DOP05: Adipose-derived stem cells from Crohn’s disease patients show antigen presenting cell-like properties
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Serena*1, M. Terrón-Puig1, M. Ejarque1, F. Algaba-Chueca1, E. Maymó-Masip1, M. Millan2, M. Menacho3, E. Espin4, M. Martí4, S. Fernández-Veledo1, J. Vendrell1

Created: Friday, 22 February 2019, 9:41 AM
DOP05: Morbid obesity, a new susceptibility factor for developing Inflammatory Bowel Disease. Results of a population-based study
Year: 2022
Source: ECCO'22
Authors: Canete Pizarro, F.C.(1);Vela, E.(2);Calafat, M.(1);Clèries, M.(2);Mañosa, M.(1);Domènech, E.(1);
Created: Friday, 11 February 2022, 3:52 PM